These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 24635967

  • 41. Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus.
    Tanaka K, Toyoda H, Kadowaki S, Hamada Y, Kosaka R, Yamanaka M, Imoto I.
    Endoscopy; 2007 Feb; 39 Suppl 1():E105-6. PubMed ID: 17440852
    [No Abstract] [Full Text] [Related]

  • 42. Introduction.
    Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S1. PubMed ID: 26422092
    [No Abstract] [Full Text] [Related]

  • 43. [Proton pump inhibition: more than only reflux therapy].
    MMW Fortschr Med; 2008 Nov 13; 150(46):48-9. PubMed ID: 19133361
    [No Abstract] [Full Text] [Related]

  • 44. Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
    Emerson CR, Marzella N.
    Clin Ther; 2010 Aug 13; 32(9):1578-96. PubMed ID: 20974316
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM, John LH, Buckley DA.
    Clin Exp Dermatol; 2011 Apr 13; 36(3):281-3. PubMed ID: 20738320
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Chemotherapy-induced subacute lupus erythematosus.
    Guhl G, Diaz-Ley B, García-García C, Fraga J, Garcia-Diez A.
    Lupus; 2009 Aug 13; 18(9):859-60. PubMed ID: 19578115
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.
    Durbin A, Callen JP, Schadt CR.
    Dermatol Ther; 2022 Dec 13; 35(12):e15959. PubMed ID: 36284259
    [No Abstract] [Full Text] [Related]

  • 55. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M.
    J Pediatr; 2009 Apr 13; 154(4):514-520.e4. PubMed ID: 19054529
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection.
    Wu IC, Wu DC, Hsu PI, Lu CY, Yu FJ, Wang TE, Chang WH, Chen JJ, Kuo FC, Wu JY, Wang WM, Bair MJ.
    Helicobacter; 2007 Dec 13; 12(6):633-7. PubMed ID: 18001406
    [Abstract] [Full Text] [Related]

  • 58. [Nocturnal shortness of breath: in asthma look for reflux -- is it worthwhile?].
    Arand M.
    MMW Fortschr Med; 2008 Dec 11; 150(51-52):16. PubMed ID: 19156949
    [No Abstract] [Full Text] [Related]

  • 59. Esomeprazole for asthma.
    Wise MP, Saayman AG, Frost PJ.
    N Engl J Med; 2009 Jul 09; 361(2):207; author reply 207-8. PubMed ID: 19593856
    [No Abstract] [Full Text] [Related]

  • 60. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M, Miwa H, Kusano M, J-FAST group.
    J Gastroenterol Hepatol; 2012 May 09; 27(5):913-8. PubMed ID: 22142515
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.